Ostarine MK-2866 Research Overview
Ostarine, also known as MK-2866, Enobosarm, GTx-024 and S-22, is one of the most recognised compounds in selective androgen receptor modulator research. It is widely discussed in the SARMs category because it is studied for androgen receptor signalling, tissue-selective marker response, anabolic pathway research, bone marker studies and endocrine feedback models.
Ostarine is not a peptide. It is a small-molecule selective androgen receptor modulator. This means its main research pathway is not connected to peptide receptor systems such as GHRH, GLP-1, GIP, glucagon or ghrelin receptors. Instead, Ostarine is studied through the androgen receptor pathway.
UK Anti-Doping lists Ostarine with the names Enobosarm and MK-2866 among common SARMs, and PubChem lists Ostarine / MK-2866 with the molecular formula C19H14F3N3O3.
Ostarine is one of the best-known SARMs research compounds because it has appeared across scientific discussion, clinical development literature, anti-doping references and online research compound categories.
What is Ostarine MK-2866
Ostarine is the common name for MK-2866. It is also known as Enobosarm, GTx-024 and S-22.
Key research identifiers include:
Compound name: Ostarine
Alternative name: Enobosarm
Research code: MK-2866
Alternative code: GTx-024
Alternative code: S-22
Compound class: Selective androgen receptor modulator
Research category: Non-steroidal SARM
Molecular formula: C19H14F3N3O3
Primary pathway: Androgen receptor signalling
The most important point is that Ostarine belongs to the SARM category. SARMs are researched because they bind to androgen receptors and may show different signalling patterns across tissue models when compared with older androgen receptor ligands.
Ostarine is therefore studied through receptor binding, gene transcription, tissue-selective response, anabolic marker pathways, skeletal marker studies and endocrine feedback markers.
It should not be confused with MK-677. MK-677, also known as Ibutamoren, is not a SARM and is studied through the ghrelin receptor pathway. Ostarine is different because its primary research identity is androgen receptor modulation.
Ostarine and androgen receptor signalling
The androgen receptor is a nuclear receptor. When a ligand binds to the androgen receptor, the receptor can change shape, move into the nucleus and influence gene transcription.
This is the core scientific reason Ostarine is studied. It gives researchers a compound for examining androgen receptor activation, transcriptional signalling and tissue-related marker response.
In research models, androgen receptor signalling may involve:
ligand binding
receptor conformational change
movement into the nucleus
binding to androgen response elements
co-regulator recruitment
gene transcription changes
anabolic marker response
tissue-selective marker patterns
endocrine feedback signals
This receptor pathway is very different from peptide receptor signalling. Peptide compounds may act through surface receptors, G protein-coupled receptor systems or growth factor pathways. Ostarine is studied through nuclear receptor biology and androgen-responsive transcription.
This makes it useful in SARM research where the focus is on receptor selectivity and marker-based interpretation.
Why Ostarine is called a SARM
Ostarine is called a SARM because it is a selective androgen receptor modulator.
The word selective does not mean the compound only affects one tissue or produces one simple response. It means researchers are interested in whether the compound can modulate androgen receptor signalling differently across different tissue models.
SARM research often examines whether a compound can show a different balance of activity across:
muscle marker models
bone marker models
prostate marker comparison
endocrine feedback markers
androgen-responsive gene expression
anabolic pathway readouts
off-target receptor screening
tissue-selective signalling
Ostarine is one of the most commonly discussed SARMs because it has become strongly associated with androgen receptor research and has appeared across both scientific and regulatory reference material.
UK Anti-Doping lists Ostarine, Enobosarm, GTx-024, MK-2866 and S-22 together as names used for the same SARM compound.
Ostarine molecular structure and classification
Ostarine is a small-molecule compound. It is not an amino acid chain and it is not a peptide.
Its molecular formula is C19H14F3N3O3, according to PubChem.
This classification matters because BioPlex Peptides supplies different categories of research compounds, and not all research compounds work through the same pathway.
A clean classification is:
Ostarine MK-2866 is a non-steroidal selective androgen receptor modulator researched through androgen receptor signalling.
It should not be described as:
a peptide
a growth hormone secretagogue
a GHRH analogue
a GLP-1 compound
a ghrelin receptor agonist
a steroid hormone
an IGF-1 analogue
Better wording includes:
selective androgen receptor modulator
non-steroidal SARM
androgen receptor ligand
small-molecule research compound
androgen receptor pathway research compound
Correct classification keeps the article clear and helps avoid confusion between SARMs, peptides, growth hormone pathway compounds and metabolic receptor agonists.
How Ostarine works in research
Ostarine is studied as an androgen receptor ligand. In research models, the compound is examined for how it binds to the androgen receptor and how that binding affects downstream transcriptional activity.
A simplified research pathway can be described as:
Ostarine interacts with the androgen receptor
the receptor changes shape
the receptor complex moves into the nucleus
androgen-responsive gene activity may change
marker panels are measured
tissue-specific responses are compared
This pathway is why Ostarine is discussed in relation to anabolic markers, skeletal tissue markers and endocrine feedback.
The important point is that Ostarine research is not based on one simple measurement. Researchers may study binding affinity, tissue marker response, receptor selectivity, time-course response, endocrine markers and comparative ligand activity.
Ostarine and tissue-selective research
Tissue selectivity is one of the most important parts of SARM research.
Androgen receptors are present across different tissue systems. A compound that binds to the androgen receptor may show different marker responses depending on the tissue model, receptor density, co-regulator environment and metabolic context.
Ostarine research may include:
muscle marker response
bone marker response
prostate marker comparison
endocrine feedback markers
anabolic pathway markers
androgenic marker comparison
gene expression panels
tissue-specific transcriptional response
This is why the term selective androgen receptor modulator is used. The research aim is not only to see whether the androgen receptor is activated, but to study how that activation behaves across different marker systems.
Ostarine is especially important because it is one of the best-known compounds in this category.
Ostarine and muscle marker research
Ostarine is frequently discussed in relation to muscle marker research because androgen receptor signalling is linked with anabolic pathway regulation.
In research-focused language, this area may include:
lean tissue marker panels
protein turnover markers
myogenic gene expression
nitrogen balance models
muscle-associated transcriptional markers
anabolic-to-androgenic marker comparison
catabolic marker review
controlled tissue response studies
The correct approach is marker-based. Ostarine should not be discussed with personal outcome claims or fitness-style wording. A research article should focus on receptor biology, tissue models and measured study endpoints.
Ostarine’s importance in this category comes from how often it appears in SARM research discussions around tissue-selective androgen receptor modulation.
Ostarine and bone marker research
Androgen receptor signalling can also be studied in skeletal tissue models. This is another reason Ostarine appears in SARM research.
Bone-related research may include:
bone turnover markers
bone mineral marker studies
osteoblast pathway research
skeletal tissue marker response
androgen receptor activity in bone models
mineralisation-related marker panels
comparative SARM studies
SARM research often includes bone marker studies because researchers are interested in how androgen receptor ligands affect skeletal marker systems compared with other tissue models.
Ostarine is relevant here because it is studied as a compound that interacts with androgen receptor pathways, which can be connected with tissue maintenance and skeletal marker interpretation.
Ostarine and endocrine feedback research
Androgen receptor signalling is part of a wider endocrine network. Because of this, Ostarine research can also include endocrine feedback markers.
Research models may review:
luteinising hormone markers
follicle-stimulating hormone markers
testosterone pathway markers
sex hormone-binding globulin markers
hypothalamic-pituitary-gonadal axis signalling
time-course marker changes
dose-response marker relationships in controlled models
Endocrine feedback matters because androgen receptor activation does not occur in isolation. Receptor activity can connect with wider hormone signalling systems and feedback loops.
This is why Ostarine research should be interpreted through a full marker panel rather than a single result.
Ostarine compared with RAD-140
Ostarine and RAD-140 both belong to the SARM category, but they are not the same compound.
RAD-140, also known as Testolone, is often discussed as a strong androgen receptor research compound. Ostarine is usually discussed as one of the most established and widely recognised SARMs research compounds.
A research comparison may include:
androgen receptor binding
tissue-selective marker response
anabolic marker activity
bone marker pathways
endocrine feedback markers
transcriptional response
off-target receptor screening
analytical identity testing
Both compounds are linked to androgen receptor research, but each has its own structure, receptor profile and marker interpretation.
Ostarine compared with Ligandrol
Ligandrol, also known as LGD-4033, is another well-known SARM. Like Ostarine, it is studied through androgen receptor signalling.
The comparison between Ostarine and Ligandrol may focus on:
androgen receptor affinity
anabolic marker response
tissue-selective activity
bone marker studies
endocrine feedback markers
clinical development history
analytical testing
compound structure
Ostarine is often discussed as one of the most recognised SARMs, while Ligandrol is also a major compound in the same category. Both are linked with selective androgen receptor modulation, but they should be studied as separate compounds.
Ostarine compared with AC-262
AC-262, also known as Accadrine or AC-262536, is another SARM research compound. It is often discussed for selective androgen receptor activity and partial agonist behaviour.
Ostarine differs because it is more widely recognised and more commonly searched. AC-262 is more niche but still relevant to androgen receptor research.
Comparison points may include:
androgen receptor activation
partial agonist behaviour
tissue-selective markers
anabolic marker models
endocrine feedback
research history
market recognition
analytical testing
Both compounds belong in the SARM category, but they should not be described as identical.
Ostarine compared with MK-677
Ostarine and MK-677 are often discussed together online, but they are scientifically different.
Ostarine is a SARM. It is studied through androgen receptor signalling.
MK-677 is not a SARM. It is a growth hormone secretagogue researched through the ghrelin receptor / GHSR pathway.
The difference is clear:
Ostarine: androgen receptor pathway
MK-677: ghrelin receptor pathway
Ostarine: selective androgen receptor modulator
MK-677: growth hormone secretagogue
Ostarine: transcriptional androgen receptor markers
MK-677: GH axis and IGF-1 marker research
This distinction is important for accurate product education. Ostarine should not be grouped mechanistically with MK-677 even if both appear in SARMs and research compound categories.
Ostarine and analytical testing
Ostarine is a small-molecule research compound, so analytical testing is important for identity and purity review.
Testing methods may include:
HPLC purity analysis
LC-MS identity confirmation
NMR structural review
quantity testing
impurity profiling
batch documentation
COA review
HPLC can help assess purity, while LC-MS can support identity by reviewing molecular mass-related data. COA documentation may provide batch-specific details depending on the supplier and testing method.
For research-focused product education, testing is important because it links the compound name to the actual material being supplied.
Ostarine and COA review
A COA, or certificate of analysis, can help customers review available product documentation. For Ostarine, COA review may include:
compound name
batch number
purity result
testing method
testing date
identity information
quantity information
laboratory details where available
COAs should be read carefully. A COA is only useful when it is clear, relevant and connected to the product being supplied.
For research compounds, COA review supports better transparency and gives customers more information about the material.
Ostarine research interpretation
Ostarine research should be interpreted through receptor-level and marker-level data.
Important interpretation points include:
which receptor assay was used
which tissue model was studied
which markers were measured
whether endocrine markers were included
whether time-course data was available
which comparator compound was used
whether analytical identity was confirmed
whether off-target receptor screening was included
A single result does not explain the full compound profile. Ostarine research is strongest when androgen receptor binding, tissue response, gene expression, endocrine markers and analytical testing are considered together.
Ostarine research summary
Ostarine MK-2866 is best understood as a non-steroidal selective androgen receptor modulator researched for androgen receptor binding, tissue-selective marker response, anabolic pathway studies, bone marker research and endocrine feedback.
Its main research themes include:
androgen receptor activation
SARM selectivity
muscle marker models
bone marker studies
endocrine feedback
gene transcription research
tissue-selective signalling
analytical purity testing
small-molecule classification
COA review
Ostarine should not be confused with peptides, GLP-1 receptor agonists, GHRH analogues or growth hormone secretagogues. Its main scientific identity is androgen receptor pathway research.
Conclusion
Ostarine, also known as MK-2866, Enobosarm, GTx-024 and S-22, is one of the most recognised compounds in selective androgen receptor modulator research. It is a small-molecule SARM studied through androgen receptor signalling, tissue-selective marker response, anabolic pathway research, bone marker studies and endocrine feedback models.
Ostarine is not a peptide. It does not belong to GHRH, GLP-1, GIP, glucagon or ghrelin receptor categories. Its main research identity is androgen receptor modulation.
Correct classification matters because SARMs and peptides are often grouped together online, even though they work through different biological pathways. Ostarine should be described as a non-steroidal selective androgen receptor modulator and androgen receptor pathway research compound.
For research interpretation, Ostarine should be reviewed through receptor binding, transcriptional activity, tissue marker response, endocrine feedback, analytical identity testing and COA documentation. This gives a clearer scientific picture than broad online descriptions.
Ostarine remains one of the strongest SEO topics in the SARMs category because it is widely recognised, commonly searched and directly connected to selective androgen receptor modulator research.
All discussion is presented strictly for educational and scientific research purposes only, supporting informed study, data interpretation, and responsible laboratory investigation.
Ostarine MK-2866
View Ostarine MK-2866 Research Compound at BioPlex Peptides ⟶
SARMs Research Compounds
View BioPlex Peptides SARMs research compounds ⟶
All discussion is presented strictly for educational and scientific research purposes only, supporting informed study, data interpretation, and responsible laboratory investigation.
